In Conversation: AnteoBind NXT Roundup

Exploring the Excitement Around AnteoBind NXT

In the latest episode of In Conversation, we dive into the growing interest and industry response to AnteoBind NXT— our next-generation surface chemistry solution. Since its launch, NXT has gained positive traction, delivering flexibility in particle size, improved cost efficiency, and a more robust approach to biomolecular conjugation.
Key topics covered in this discussion include:

• Market Response to NXT – Early results and feedback from customer presentations
• Expanding Applications – How NXT is supporting IVD, biologics, vaccine manufacturers, and biosensor developers, particularly in India
• Insights from India – The challenges companies face with reproducibility and how NXT is addressing critical gaps in the market
• Beyond NXT – Updates on AnteoTech’s contract services and exciting new work with microparticles

“One of the biggest takeaways from our recent trip to India was the increasing demand for flexible, scalable and reproducible bioconjugation chemistries. The reception to AnteoBind NXT has been incredibly positive, with referrals growing through word-of-mouth.”